United Therapeutics Corp - Company Profile
Powered by
All the data and insights you need on United Therapeutics Corp in one report.
- Save hours of research time and resources with
our up-to-date United Therapeutics Corp Strategy Report
- Understand United Therapeutics Corp position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
United Therapeutics Corp (United Therapeutics) develops and markets therapeutic products for pulmonary arterial hypertension, cancer, and infectious diseases. A robust portfolio of PAH products, focus on R&D and strong domestic presence are its strengths, even as litigations and lawsuits could be a cause for concern to the company. United Therapeutics could benefit from the market potential for PAH, increasing healthcare expenditure in the US and approvals and launch of new products, which could provide growth opportunities to the company. However, uncertain R&D outcomes, stringent government regulations and intense competition could pose challenges to its operations and financial performance.
Strengths
Weaknesses
Opportunities
Threats
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer